Last update 10 May 2025

CN117479934

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
HIPK2 x SMAD3
Action
inhibitors
Mechanism
HIPK2 inhibitors(homeodomain interacting protein kinase 2 inhibitors)
Therapeutic Areas
Respiratory DiseasesSkin and Musculoskeletal DiseasesUrogenital Diseases+ [1]
Active Indication
Collagen DiseasesOther DiseasesPulmonary Fibrosis+ [1]
Inactive Indication-
Originator Organization
United States Department of Veterans AffairsUnited States Department of Veterans AffairsIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai
Active Organization
Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount SinaiUnited States Department of Veterans AffairsUnited States Department of Veterans Affairs
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with CN117479934
Login to view more data
100 Translational Medicine associated with CN117479934
Login to view more data
100 Patents (Medical) associated with CN117479934
Login to view more data
100 Deals associated with CN117479934
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Collagen DiseasesDiscovery-
Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai
30 Jan 2024
Collagen DiseasesDiscovery-
United States Department of Veterans AffairsUnited States Department of Veterans Affairs
30 Jan 2024
Other DiseasesDiscovery-
Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai
30 Jan 2024
Other DiseasesDiscovery-
United States Department of Veterans AffairsUnited States Department of Veterans Affairs
30 Jan 2024
Pulmonary FibrosisDiscovery-
Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai
30 Jan 2024
Pulmonary FibrosisDiscovery-
United States Department of Veterans AffairsUnited States Department of Veterans Affairs
30 Jan 2024
Renal fibrosisDiscovery-
Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai
30 Jan 2024
Renal fibrosisDiscovery-
United States Department of Veterans AffairsUnited States Department of Veterans Affairs
30 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free